Abstract
In vitro susceptibility to 17 antimicrobial agents was determined for Aeromonas caviae, A. hydrophila, and A. sobria isolated from feces of patients with diarrhea. The three Aeromonas species shared a similar susceptibility pattern, except to cephalothin. Of the oral antimicrobial agents, the quinolones, followed by chloramphenicol, were most active; trimethoprim-sulfamethoxazole and tetracycline had good but variable activity.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agger W. A., McCormick J. D., Gurwith M. J. Clinical and microbiological features of Aeromonas hydrophila-associated diarrhea. J Clin Microbiol. 1985 Jun;21(6):909–913. doi: 10.1128/jcm.21.6.909-913.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burke V., Gracey M., Robinson J., Peck D., Beaman J., Bundell C. The microbiology of childhood gastroenteritis: Aeromonas species and other infective agents. J Infect Dis. 1983 Jul;148(1):68–74. doi: 10.1093/infdis/148.1.68. [DOI] [PubMed] [Google Scholar]
- Fainstein V., Weaver S., Bodey G. P. In vitro susceptibilities of Aeromonas hydrophila against new antibiotics. Antimicrob Agents Chemother. 1982 Sep;22(3):513–514. doi: 10.1128/aac.22.3.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J., Barnishan J. In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents. Antimicrob Agents Chemother. 1981 Feb;19(2):357–358. doi: 10.1128/aac.19.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Figura N., Marri L., Verdiani S., Ceccherini C., Barberi A. Prevalence, species differentiation, and toxigenicity of Aeromonas strains in cases of childhood gastroenteritis and in controls. J Clin Microbiol. 1986 Mar;23(3):595–599. doi: 10.1128/jcm.23.3.595-599.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gracey M., Burke V., Robinson J. Aeromonas-associated gastroenteritis. Lancet. 1982 Dec 11;2(8311):1304–1306. doi: 10.1016/s0140-6736(82)91510-0. [DOI] [PubMed] [Google Scholar]
- Janda J. M., Motyl M. R. Cephalothin susceptibility as a potential marker for the Aeromonas sobria group. J Clin Microbiol. 1985 Nov;22(5):854–855. doi: 10.1128/jcm.22.5.854-855.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Janda J. M., Reitano M., Bottone E. J. Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum. J Clin Microbiol. 1984 Jan;19(1):44–47. doi: 10.1128/jcm.19.1.44-47.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motyl M. R., McKinley G., Janda J. M. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents. Antimicrob Agents Chemother. 1985 Jul;28(1):151–153. doi: 10.1128/aac.28.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reinhardt J. F., George W. L. Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides. Antimicrob Agents Chemother. 1985 Apr;27(4):643–645. doi: 10.1128/aac.27.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Richardson C. J., Robinson J. O., Wagener L. B., Burke V. In-vitro susceptibility of Aeromonas app. to antimicrobial agents. J Antimicrob Chemother. 1982 Apr;9(4):267–274. doi: 10.1093/jac/9.4.267. [DOI] [PubMed] [Google Scholar]
- Travis L. B., Washington J. A., 2nd The clinical significance of stool isolates of aeromonas. Am J Clin Pathol. 1986 Mar;85(3):330–336. doi: 10.1093/ajcp/85.3.330. [DOI] [PubMed] [Google Scholar]